Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Myelogenous Leukemia
>>
Pfizer
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Atgam
(equine anti-thymocyte globulin) / Pfizer
Sutent
(sunitinib) / Pfizer
Ibrance
(palbociclib) / Pfizer
Talzenna
(talazoparib) / Pfizer
Adcetris
(brentuximab vedotin) / Takeda, Pfizer
Mektovi
(binimetinib) / Ono Pharma, Pierre Fabre, Pfizer
Torisel
(temsirolimus) / Pfizer
Inlyta
(axitinib) / Pfizer
Xalkori
(crizotinib) / Pfizer
Enbrel
(etanercept) / Pfizer, Amgen
Koselugo
(selumetinib) / Merck (MSD), AstraZeneca
filanesib
(ARRY-520) / Pfizer
semaxanib
(SU5416) / Pfizer
